RLAY Q1 2025 Earnings — Relay Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

RLAYRelay Therapeutics, Inc.

$2B

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$8M-23.3% YoY

Gross Profit

$8M100.0% margin

Operating Income

-$85M-1105.2% margin

Net Income

-$77M-1003.6% margin

EPS (Diluted)

$-0.46

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$73M

Free Cash Flow

-$74M

Stock-Based Comp.

$19M

Balance Sheet

Total Assets

$799M

Total Liabilities

$78M

Stockholders' Equity

$721M

Cash & Equivalents

$94M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$10M	-23.3%
Gross Profit	$8M	$10M	-23.3%
Operating Income	-$85M	-$90M	+6.1%
Net Income	-$77M	-$81M	+5.3%